89 related articles for article (PubMed ID: 20728692)
1. Introduction to the special issue on Alzheimer's disease.
Pangalos MN; Randall AD
Neuropharmacology; 2010; 59(4-5):219-20. PubMed ID: 20728692
[No Abstract] [Full Text] [Related]
2. Introduction to special issue on Alzheimer's disease.
Wolfe MS
J Med Chem; 2012 Nov; 55(21):8977-8. PubMed ID: 23039833
[No Abstract] [Full Text] [Related]
3. [Abeta/tau soluble complexes to solve the insolvable question of Alzheimer's disease primary cause].
Epelbaum J
Med Sci (Paris); 2006 May; 22(5):462-3. PubMed ID: 16687104
[No Abstract] [Full Text] [Related]
4. [The role of cholesterol in the pathogenesis of Alzheimer's disease].
Michikawa M
Nihon Ronen Igakkai Zasshi; 2001 Nov; 38(6):751-3. PubMed ID: 11774713
[No Abstract] [Full Text] [Related]
5. Alzheimer's disease: a general introduction and pathomechanism.
Finder VH
J Alzheimers Dis; 2010; 22 Suppl 3():5-19. PubMed ID: 20858960
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanism underlying the development of Alzheimer's disease: implications of apolipoprotein E and presenilin].
Yanagisawa K
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):455-7. PubMed ID: 11523146
[No Abstract] [Full Text] [Related]
7. Constellation of risks and processes seen in search for Alzheimer's clues.
Cotton P
JAMA; 1994 Jan; 271(2):89-91. PubMed ID: 8264073
[No Abstract] [Full Text] [Related]
8. The search for effective Alzheimer's therapies: a work in progress.
Bor JS
Health Aff (Millwood); 2014 Apr; 33(4):527-33. PubMed ID: 24711310
[No Abstract] [Full Text] [Related]
9. [Alzheimer's disease and apolipoprotein E].
Yamaguchi H
No To Shinkei; 1996 Nov; 48(11):981-90. PubMed ID: 8951889
[No Abstract] [Full Text] [Related]
10. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.
Anthony IC; Norrby KE; Dingwall T; Carnie FW; Millar T; Arango JC; Robertson R; Bell JE
Brain; 2010 Dec; 133(Pt 12):3685-98. PubMed ID: 21126996
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E receptors: linking brain development and Alzheimer's disease.
Herz J; Beffert U
Nat Rev Neurosci; 2000 Oct; 1(1):51-8. PubMed ID: 11252768
[TBL] [Abstract][Full Text] [Related]
12. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).
Buerger K; Frisoni G; Uspenskaya O; Ewers M; Zetterberg H; Geroldi C; Binetti G; Johannsen P; Rossini PM; Wahlund LO; Vellas B; Blennow K; Hampel H
Exp Gerontol; 2009 Sep; 44(9):579-85. PubMed ID: 19539742
[TBL] [Abstract][Full Text] [Related]
13. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol and pathological processes in Alzheimer's disease.
Yanagisawa K
J Neurosci Res; 2002 Nov; 70(3):361-6. PubMed ID: 12391598
[TBL] [Abstract][Full Text] [Related]
15. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
[TBL] [Abstract][Full Text] [Related]
16. Insights from Drosophila models of Alzheimer's disease.
Cowan CM; Shepherd D; Mudher A
Biochem Soc Trans; 2010 Aug; 38(4):988-92. PubMed ID: 20658990
[TBL] [Abstract][Full Text] [Related]
17. Development of tau aggregation inhibitors for Alzheimer's disease.
Bulic B; Pickhardt M; Schmidt B; Mandelkow EM; Waldmann H; Mandelkow E
Angew Chem Int Ed Engl; 2009; 48(10):1740-52. PubMed ID: 19189357
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment.
Garg S; Timm T; Mandelkow EM; Mandelkow E; Wang Y
Neurobiol Aging; 2011 Jan; 32(1):1-14. PubMed ID: 20961659
[TBL] [Abstract][Full Text] [Related]
19. Links between ApoE, brain cholesterol metabolism, tau and amyloid beta-peptide in patients with cognitive impairment.
Leoni V; Solomon A; Kivipelto M
Biochem Soc Trans; 2010 Aug; 38(4):1021-5. PubMed ID: 20658997
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenesis of Alzheimer's disease].
Alegre M; Noé E; Luquin MR
Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
